Overview
Benedito Carneiro-Filho is an Oncologist in Providence, Rhode Island. Dr. Carneiro-Filho is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, and Adult Soft Tissue Sarcoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
593 Eddy St, Apc 138, Providence, RI 02903
Prospect Chartercare Rwmc, LLC
Ritesh Rathore is a Hematologist Oncology specialist and a Hematologist in Providence, Rhode Island. Dr. Rathore is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Pancreatic Cancer, Bone Marrow Transplant, and Colonoscopy.
Prospect Chartercare Rwmc, LLC
Bharti Rathore is a Hematologist Oncology specialist and a Hematologist in Providence, Rhode Island. Dr. Rathore is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Pseudomyxoma Peritonei, Anemia, Childhood Iron Deficiency Anemia, and Iron Deficiency Anemia.
Dana-Farber Cancer Institute, Inc.
Ursula Matulonis is an Oncologist in Boston, Massachusetts. Dr. Matulonis is rated as an Elite provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, and Tubal Ligation. Dr. Matulonis is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Soft Tissue SarcomaDr. Carneiro-Filho isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Carneiro-Filho isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Carneiro-Filho isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Carneiro-Filho isDistinguished. Learn about Familial Wilms Tumor 2.
- Penile CancerDr. Carneiro-Filho isDistinguished. Learn about Penile Cancer.
- Renal Cell Carcinoma (RCC)Dr. Carneiro-Filho isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Advanced
- AngiosarcomaDr. Carneiro-Filho isAdvanced. Learn about Angiosarcoma.
- Bladder CancerDr. Carneiro-Filho isAdvanced. Learn about Bladder Cancer.
- Bone TumorDr. Carneiro-Filho isAdvanced. Learn about Bone Tumor.
- Epithelioid SarcomaDr. Carneiro-Filho isAdvanced. Learn about Epithelioid Sarcoma.
- Familial Pancreatic CancerDr. Carneiro-Filho isAdvanced. Learn about Familial Pancreatic Cancer.
- Familial Prostate CancerDr. Carneiro-Filho isAdvanced. Learn about Familial Prostate Cancer.
- Experienced
- Adrenal CancerDr. Carneiro-Filho isExperienced. Learn about Adrenal Cancer.
- ALK-Positive Non-Small Cell Lung CancerDr. Carneiro-Filho isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anaplastic Thyroid CancerDr. Carneiro-Filho isExperienced. Learn about Anaplastic Thyroid Cancer.
- Appendix CancerDr. Carneiro-Filho isExperienced. Learn about Appendix Cancer.
- Colorectal CancerDr. Carneiro-Filho isExperienced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerDr. Carneiro-Filho isExperienced. Learn about EGFR Positive Lung Cancer.